非编码RNAs在调节乳腺癌PD-L1表达中的作用:新兴见解和影响
Jianqin Zhu1, Weijin Zhu2, Xulin Zhou3
1School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Current cancer drug targets
|June 20, 2025
概括
非编码RNAs (ncRNAs) 调节乳腺癌中编程细胞死亡配体1 (PD-L1),影响免疫逃避和治疗抵抗. 了解这些ncRNA机制为个性化疗法提供了新的途径,将ncRNA治疗与PD-L1抑制剂结合起来.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 乳腺癌的进展涉及复杂的免疫调节,编程细胞死亡配体1 (PD-L1) 对于免疫逃避和促进瘤的微环境至关重要.
- 非编码RNAs (ncRNAs) 越来越多地被认为是它们在调节PD-L1表达中的作用,影响瘤发生和乳腺癌的治疗抵抗.
- 澄清控制PD-L1表达的替代调节机制对于推进乳腺癌治疗策略至关重要.
研究的目的:
- 在不同乳腺癌亚型中划分PD-L1表达的变化.
- 阐明ncRNAs调节PD-L1表达的特定机制.
- 探索结合基于ncRNA的疗法与PD-L1抑制剂用于个性化乳腺癌治疗的潜力和挑战.
主要方法:
- 在各种乳腺癌亚型中分析PD-L1表达模式.
- 对ncRNA参与PD-L1.1调节的研究.
- 对 ncRNA 和 PD-L1 抑制剂联合治疗的临床前数据的评估.
主要成果:
- 确定了与特定乳腺癌亚型相关的PD-L1表达的独特模式.
- 描述了影响PD-L1水平的新型ncRNA介导途径.
- 在临床前模型中证明了ncRNA疗法和PD-L1抑制剂之间的协同作用的可行性和潜在益处.
结论:
- ncRNAs在乳腺癌中调节PD-L1表达方面发挥着重要作用,有助于免疫逃避和治疗耐药性.
- 向ncRNAs提供了一种有希望的策略,以克服对PD-L1抑制剂的耐药性.
- 结合基于ncRNA和PD-L1抑制剂的疗法代表了更个性化和更有效的乳腺癌治疗的潜在途径.
相关概念视频
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Types of RNA
66.2K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
66.2K
Negative Regulator Molecules
36.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.2K
Regulation of Expression at Multiple Steps
1.0K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.0K


